Opinion|Videos|December 23, 2024

Navigating HER2 Heterogeneity: Precision Pathways in Breast Cancer Treatment

A panelist discusses how differences in HER2-positive, HER2-low, and HER2-negative status impact clinical decision-making.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME